Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. (Q40643169)

22 September 2017

Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. (English)

1 reference

22 September 2017

0 references

5

Sue E Leurgans

1 reference

22 September 2017

6

Jeffrey H Kordower

1 reference

22 September 2017

Jodi L McBride

1

1 reference

22 September 2017

Matthew J During

series ordinal

2

1 reference

22 September 2017

Joanne Wuu

series ordinal

3

1 reference

22 September 2017

Er Yun Chen

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

22 September 2017

Experimental Neurology

1 reference

22 September 2017

181

1 reference

22 September 2017

2

1 reference

22 September 2017

213-223

1 reference

Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Replicating Huntington's disease phenotype in experimental animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Huntington disease: Estimation of heterozygote status using linked genetic markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Adeno-associated virus effectively mediates conditional gene modification in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Longitudinal data analysis for discrete and continuous outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

Neuropathological classification of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900044-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-4886(03)00044-X

1 reference

22 September 2017

1 reference